Zhao et al. reported a correlation between Trop-2 mRNA and protein expression levels and several clinical prognostic indicators in breast cancer, including lymph node status, metastasis, stage, and estrogen receptor/progesterone receptor/HER2 expression. This evidence concerns the gene TACSTD2 and breast carcinoma.